Target intelligence / Profile preview

Casitas B-lineage Lymphoma Proto-oncogene B (Cbl-b)

Target
Cbl-b
Molecular classification
E3 Ubiquitin-protein Ligase, Enzyme
01

Overview

Cbl-b is an E3 ubiquitin-protein ligase that acts as a negative regulator of immune cell activation, particularly in T cells and B cells. It controls ligand-induced down-modulation of the T cell receptor (TCR) and regulates signaling through the B cell receptor (BCR). As an E3 ubiquitin ligase, it targets key signaling molecules for ubiquitination-mediated degradation or signal attenuation. Targeting/inhibiting Cbl-b has emerged as a promising strategy for cancer immunotherapy.

Other names
CBLBE3 ubiquitin-protein ligase CBLB
02

Mechanism of action

Ubiquitination-mediated downregulation/degradation of target proteins

03

Biological functions

Immune responseNegative regulation of immune cell activationUbiquitinationSignal transduction
04

Disease associations

CancerAutoimmune diseases
05

Safety considerations

Heightened immune responses leading to autoimmunity (with deficiency/mutation)Impaired anti-tumor immunity (with gain-of-function)

Beyond the preview

Go deeper on Casitas B-lineage Lymphoma Proto-oncogene B (Cbl-b).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Casitas B-lineage Lymphoma Proto-oncogene B (Cbl-b).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call